938547318            nvh            73144509            6/29/2002 12:00:00 amchoreoathetosisdisadmission date :            06/29/2002report status :discharge date :            07/04/2002 discharge orders            tlandstreu , sonmyrn            674-98-72-3b73room :            25y-975service :neudischarge patient on :            independence day at 11:30 amcontingent upon not applicablewill d / c order be used as the d / csummary :yesattending :            drepsfel , ma tera , m.d.disposition :rehabilitationdischarge medications :tylenol ( acetaminophen ) 650 mg po q4h prn headache colace ( docusate sodium ) 100 mg po bid folate ( folic acid ) 1 mg po qd thiamine hcl 100 mg po qd mvi therapeutic ( therapeutic multivitamins ) 1 tab po qd zyprexa ( olanzapine ) 5 mg po qhs starting today ( 07/04 )number of doses required ( approximate ) :5diet :no restrictionsactivity - ambulate with assistfollow up appointment ( s ) :follow up with dr. briz within 4 weeks , no known allergiesadmit diagnosis :movement disorderprincipal discharge diagnosis ; responsible after study for causing admission ) choreoathetosisother diagnosis ; conditions , infections , complications , affecting treatment / staynoneoperations and procedures :other treatments / procedures ( not in o.r. )nonebrief resume of hospital course :patient is an 80 year old female with a history of dementia , and of a choreoathetotic movement disorder of unclear etiology .she has had these problems for approximately 10 years , and is cared for by a family member .w / u for huntington 's , ceruloplasmin , tsh , etc have all been negative in the past .now presents with report of sub-acute worsening of confusion .patient was admitted to neurology service .she had a gradual imporvement of her confusion back towards baseline during the hospital stay .the major therapeutic change during the hospitalization was the starting of zyprexa to see if as part of its side-effect profile it would decrease the choreoathetotic movement symptoms .infact , this medication was found to cause a significant improvement in her choreoathetotic perioral and arm movements .she still has significant myoclonic component in her arms especially with volition , but this med will certainly be continued .while essentially what we are hoping for in this use of the med is extra-pyramidal side effects , she should be monitored for any excessive or debilitating parkinsonian symptoms such as excessive rigidity .additional comments :discharge condition :stableto do / plan :no dictated summaryentered by :            leung , luanme a. , m.d. ( rw156 )            07/04/02 11:25 am end of discharge orders